Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Valtorcitabine - Combination Drug Therapy for Chronic Hepatitis B



Cirrhosis of the liver is a common complication of HBV infection that can lead to hepatic insufficiency, portal hypertension and cancer of the liver.


  • Current estimates suggest that 350-400 million people are infected with HBV.

  • Cirrhosis of the liver is a common complication of HBV infection that can...

  • Telbivudine is the most recently approved drug for the treatment of chronic...

  • Therapeutic goals for chronic HBV infection include clearance of HBeAg and...

Back to Project Details



Related Projects

Fablyn (Lasofoxifene) - Investigational SERM
The product of a joint development programme between Pfizer and...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Avastin (bevacizumab) - Angiogenesis
The product of a joint development programme between Genentech and...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.